RNU6-939P

Across TCGA pan-cancer cohorts, RNU6-939P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU6-939P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RNU6-939P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-939P expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.

LIHC, KICH, and CHOL are the cancer types where RNU6-939P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.063	0.546	<.001	114	view →
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
CHOL	OS	Tertile	All	0.133	0.743	<.001	54	view →
STAD	OS	Tertile	III,IV	0.166	0.638	<.001	45	view →
OV	OS	Tertile	IV	0.028	0.759	.002	36	view →
LUSC	DFS	Tertile	II,III,IV	0.214	0.614	.010	33	view →
KIRC	OS	Tertile	II,III,IV	0.400	0.723	.022	30	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	24	view →
LUAD	DFS	Tertile	All	0.533	0.772	.044	9	view →
BLCA	OS	Tertile	All	0.861	0.597	.034	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU6-939P–LIHC (DFS)

Open the LIHC breakdown →